meglumine has been researched along with Body Weight in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 8 (57.14) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cedeño, DL; Fernandez, M; Jones, MA; Murillo, J; Ocampo-Cardona, R; Ríos-Vásquez, LA; Robledo, SM; Velez, ID | 1 |
| Claussen, CD; Fenchel, M; Hoevelborn, T; Klumpp, BD; Kramer, U; Lodemann, KP; Miller, S; Sandstede, J; Seeger, A | 1 |
| Aresu, L; Bianciardi, P; Brovida, C; Castagnaro, M; Cavicchioli, L; Giroud, L; Valente, M; Vischer, C | 1 |
| Desché, P | 1 |
| Evans, TG; Hibbs, JB; Reed, SS | 1 |
| Bussi, S; Masters, RE; Morisetti, A; Sagami, F; Sekido, T; Tirone, P | 1 |
| Aoki, T; Bussi, S; Masters, RE; Morisetti, A; Sagami, F; Tirone, P | 1 |
| Bussi, S; Katsutani, N; Mandella, RC; Morisetti, A; Sagami, F; Tirone, P | 1 |
| Baguley, JK; Bussi, S; Morisetti, A; Okada, F; Sagami, F; Tirone, P | 1 |
| Bussi, S; Masters, RE; Morisetti, A; Okuda, Y; Sagami, F; Tirone, P | 1 |
| Campbell, BJ; Dimaline, R; Dockray, GJ; Hughes, J | 1 |
| Hanson, WL; Klayman, DL; Lovelace, JK; Vennerstrom, JL; Waits, VB | 1 |
| Chapman, WL; Hanson, WL; White, MR | 1 |
| Atkins, LM; Basinger, MA; Gale, GR; Jones, MM; Jones, SG; Smith, AB | 1 |
1 trial(s) available for meglumine and Body Weight
| Article | Year |
|---|---|
Re: Cerebral neoplastic enhancing lesions: Multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting.
Topics: Body Weight; Brain Neoplasms; Contrast Media; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2012 |
13 other study(ies) available for meglumine and Body Weight
| Article | Year |
|---|---|
In vivo studies of the effectiveness of novel N-halomethylated and non-halomethylated quaternary ammonium salts in the topical treatment of cutaneous leishmaniasis.
Topics: Administration, Topical; Animals; Antiprotozoal Agents; Body Weight; Cricetinae; Disease Models, Animal; Female; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Quaternary Ammonium Compounds; Salts; Skin; Toxicity Tests | 2018 |
Intraindividual comparison of myocardial delayed enhancement MR imaging using gadobenate dimeglumine at 1.5 T and 3 T.
Topics: Adult; Aged; Body Weight; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Models, Statistical; Myocardium; Organometallic Compounds; Reproducibility of Results; Ventricular Function, Left | 2009 |
Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys.
Topics: Animals; Antiprotozoal Agents; Body Weight; Dogs; Female; Fluorescent Antibody Technique; Histocytochemistry; Kidney; Kidney Diseases; Kidney Tubules; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Microscopy, Electron; Organometallic Compounds; Phosphorylcholine; Random Allocation; Toxicity Tests | 2009 |
Nitric oxide production in murine leishmaniasis: correlation of progressive infection with increasing systemic synthesis of nitric oxide.
Topics: Animals; Antiprotozoal Agents; Body Weight; Disease Progression; Injections, Intraperitoneal; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Nitric Oxide; Organometallic Compounds; Species Specificity | 1996 |
[General toxicity study of gadobenate dimeglumine formulation (E7155) (2)--Single dose intravenous toxicity study in dogs].
Topics: Animals; Blood Chemical Analysis; Body Weight; Contrast Media; Dogs; Eating; Female; Gadolinium; Hematologic Tests; Injections, Intravenous; Lethal Dose 50; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Urinalysis | 1999 |
[General toxicity study of gadobenate dimeglumine formulation (E7155) (3)--4-week repeated dose intravenous toxicity study followed by 4-week recovery period in rats].
Topics: Animals; Blood Chemical Analysis; Body Weight; Contrast Media; Drinking; Eating; Eye; Female; Gadolinium; Hematologic Tests; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Organ Size; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Time Factors; Urinalysis | 1999 |
[General toxicity study of gadobenate dimeglumine formulation (E7155) (4)--4-week repeated dose intravenous toxicity study followed by 4-week recovery period in dogs].
Topics: Animals; Body Weight; Contrast Media; Dogs; Drinking; Eating; Electrocardiography; Female; Gadolinium; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Time Factors; Urinalysis | 1999 |
[Reproductive and developmental toxicity study of gadobenate dimeglumine formulation (E7155) (1)--Fertility study in male rats by intravenous administration].
Topics: Animals; Body Weight; Contrast Media; Female; Fertility; Gadolinium; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Organ Size; Organometallic Compounds; Pregnancy; Rats; Rats, Sprague-Dawley; Sperm Count; Sperm Motility | 1999 |
[Reproductive and developmental toxicity study of gadobenate dimeglumine formulation (E7155) (3)--Study of embryo-fetal toxicity in rabbits by intravenous administration].
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Contrast Media; Embryo, Mammalian; Female; Fetal Death; Fetus; Gadolinium; Injections, Intravenous; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rabbits; Teratogens | 1999 |
Inhibition of food intake by omeprazole in the chicken.
Topics: Animals; Animals, Newborn; Body Weight; Chickens; Depression, Chemical; Eating; Gastrins; Indoles; Meglumine; Omeprazole; Radioimmunoassay; Receptors, Cholecystokinin; Satiety Response | 1991 |
Berberine derivatives as antileishmanial drugs.
Topics: Animals; Antiprotozoal Agents; Berberine; Berberine Alkaloids; Body Weight; Cricetinae; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Skin | 1990 |
Chemotherapy of experimental visceral leishmaniasis in the opossum.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Body Weight; Female; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Opossums; Organ Size; Organometallic Compounds; Sorbitol; Spleen | 1989 |
N-alkyl-N-dithiocarboxy-D-glucamine analogs as cadmium antagonists: synthesis and evaluation of the n-propyl, n-butyl, and n-amyl derivatives.
Topics: Animals; Body Weight; Cadmium; Chemical Phenomena; Chemistry; Chemistry, Physical; Dose-Response Relationship, Drug; Male; Meglumine; Metallothionein; Mice; Mice, Inbred ICR; Organ Size; Solubility; Sorbitol; Thiocarbamates; Tissue Distribution | 1988 |